ClinicaliQ Trial Snapshot
- Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants — Recruiting • Phase I • Rheumatology • NCT07201558.
- Early-stage trial testing a new injection drug's safety, tolerability, and how the body processes it in patients with rheumatoid arthritis or lupus.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration to participants with RA or SLE. Conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus Interventions: Surovatamig Lead Sponsor: AstraZeneca Planned Enrollment: 48 participants